WHO launches global strategy to eliminate cervical cancer by 2030
The World Health Organisation (WHO) has launched a global strategy to accelerate the elimination of cervical cancer by 2030.
Source: tribuneonlineng.com
Page 33 - Merck Sharp News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Merck Sharp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Merck Sharp Today - Breaking & Trending Today
Lower-Dose Belzutifan Deemed Appropriate for Advanced Clear Cell RCC
A 120 mg daily dose of belzutifan is appropriate for previously treated, advanced clear cell RCC, results from the LITESPARK-013 trial suggest. A 120 mg daily dose of belzutifan is appropriate for previously treated, advanced clear cell RCC, results from the LITESPARK-013 trial suggest.
Source: renalandurologynews.com
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Patients with gastric or GEJ adenocarcinoma whose tumors express PD-L1 can now be identified for potential treatment with KEYTRUDA® using PD-L1 IHC 22C3 pharmDx ...
Source: marketscreener.com
IO Biotech Appoints Helen Collins, MD, to its Board of Directors
IO Biotech Appoints Helen Collins, MD, to its Board of Directors
Source: pharmiweb.com
IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma
Trial expected to reach the primary endpoint of progression free survival in the second half of 2025 Per-protocol interim analysis expected in mid...
Source: businessinsider.com